⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Methylphenidate

متیل‌فنیدیت

⚠ Unverified

🧠 PsychiatryCNS stimulant

Market / country: 🇺🇸 USA

Ritalin (US)

🧮 Dose calculator

Disease / regimen

Attention-deficit/hyperactivity disorder · Regimen source: FDA Ritalin · 2.2 FDA Ritalin · 8.4

• Before breakfast and lunch; increase 5–10 mg weekly; above 60 mg/day not recommended. Discontinue if no improvement after one month. FDA Ritalin · 2.2 FDA Ritalin · 2.3
• Before starting: screen for cardiac disease, family history of sudden death, tics/Tourette's. FDA Ritalin · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ MAOI within 14 days (hypertensive crisis); hypersensitivity. FDA Ritalin · 4
⛔ Not established under 6 years. FDA Ritalin · 8.4

Warnings

• Boxed warning: high potential for abuse, misuse and addiction; risk of overdose and death. FDA Ritalin · WARNING: ABUSE, MISUSE, AND ADDICTION

Monitoring

• Monitor growth (height and weight) during treatment. FDA Ritalin · 8.4

Formulations

5 mg tablet — tablet 🇺🇸 USA FDA Ritalin · 3
10 mg tablet (partial bisection) — tablet 🇺🇸 USA FDA Ritalin · 3
20 mg tablet (partial bisection) — tablet 🇺🇸 USA FDA Ritalin · 3

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Ritalin · 3 FDA Ritalin · 2.2 FDA Ritalin · 8.4 FDA Ritalin · 2.3 FDA Ritalin · 2.1 FDA Ritalin · 4 FDA Ritalin · WARNING: ABUSE, MISUSE, AND ADDICTION
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Clinical review⚠ Unverified

🔗 Similar drugs

For the same diseases

Atomoxetine